Kilale A M, Ngowi B J, Mfinanga G S, Egwaga S, Doulla B, Kumar A M V, Khogali M, van Griensven J, Harries A D, Zachariah R, Hinderaker S G
National Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, Tanzania ; Centre for International Health, University of Bergen, Norway.
National Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
Public Health Action. 2013 Jun 21;3(2):156-9. doi: 10.5588/pha.12.0103.
One reference and three zonal laboratories and 500 health facilities managing retreatment tuberculosis (TB) patients in Tanzania.
The National Tuberculosis and Leprosy Programme (NTLP) requires that all notified cases of retreatment TB in Tanzania have sputum samples sent for culture and drug susceptibility testing (DST). This study determined 1) if the number of annually notified retreatment patients corresponded to the number of sputum samples received by the reference laboratories, and 2) the number of culture-positive samples and the number of cases undergoing DST.
Nine-year audit of country-wide programme data from 2002 to 2010.
Of the 40 940 retreatment TB patients notified by the NTLP, 3871 (10%) had their sputum samples received at the reference and zonal laboratories for culture and DST. A total of 3761 (97%) sputum samples were processed for culture, of which 1589 (42%) were found to be culture-positive and 1415 (89%) had DST performed.
There is a >90% shortfall between notified retreatment cases and numbers of sputum samples received, cultured and assessed for DST at reference and zonal laboratories. Steps needed to address this problem are discussed.
在坦桑尼亚,一个参考实验室、三个区域实验室以及500家负责管理复治结核病患者的医疗机构。
国家结核病和麻风病防治规划(NTLP)要求,坦桑尼亚所有通报的复治结核病病例都要送痰标本进行培养和药敏试验(DST)。本研究旨在确定:1)每年通报的复治患者数量是否与参考实验室收到的痰标本数量相符;2)培养阳性标本数量以及接受DST的病例数量。
对2002年至2010年全国项目数据进行为期九年的审计。
在NTLP通报的40940例复治结核病患者中,有3871例(10%)的痰标本被送到参考实验室和区域实验室进行培养和DST。总共3761例(97%)痰标本进行了培养,其中1589例(42%)培养阳性,1415例(89%)进行了DST。
通报的复治病例与参考实验室和区域实验室收到、培养并进行DST评估的痰标本数量之间存在超过90%的差距。文中讨论了解决该问题所需采取的措施。